Cyfra 21-1 antigen - serum
Back to the listEurofins Biomnis code
CYF
Synonyms
- Cyfra 21-1
Specialty
Biochemistry
Clinical significance
A good marker for bronchopulmonary malignancies other than small cell carcinoma, i.e. large cell and squamous cell carcinomas. Its levels may also be slightly elevated in patients with non-malignant lung disease (e.g. tuberculosis and pulmonary embolism).
Further information
ATTENTION: interference possible in patients treated with biotin (vitamin B7, B8 or H) or taking any food supplement containing biotin. Essential to STOP treatment 8 days before taking the sample.
Methodology
Electrochemiluminescence
Turnaround time
1 day
Testing Laboratory
Biomnis Ivry
Contact(s)
Customer Care